Sunday, November 17, 2019
wellness India Expo
Home Tags Pharma

Tag: Pharma

Abbott announces discovery of new HIV strain

Discovery marks the first time a new subtype of HIV-1 has been identified since 2000. Abbott is making this new strain accessible to the research community to evaluate its impact to diagnostic testing, treatments and potential vaccines...............

TB Alliance & Macleods partner to develop new therapy for highly...

Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence of TB.....................

USV sets up new plant at Vadodara

With an initial capital investment of around Rs 4000 million, the facility will provide employment to more than 350 people, despite being a very highly automated plant.........................

Roche appoints Omar Sherief Mohammad as new General Manager for India

Omar joins from Novo Nordisk, Vietnam where he was the General Manager, Southeast Asia - Emerging Markets...............

One year of Ayushman Bharat: MedTech & Pharma sectors expected to...

Within the healthcare industry, the medical devices segment is expected to be the biggest beneficiary, with additional revenues of USD 2 billion.................

‘Health Meets Hope’ at OPPI Health Dialogue 2019

The Health Dialogue 2019, curated by the Organisation of Pharmaceutical Producers of India witnessed the launch of #RefreshingResearch, a nation-wide digital campaign across pharma colleges. Research papers released at the event included.............

Sun Pharma makes an entry into generic pharma market in Mainland...

Sun Pharma and China Medical System Holdings have entered into licensing agreement for generic products in Mainland China..............

India’s biosimilars market stays buoyant

The entire gamut of biologic drugs, of which biosimilars are crucial, is set to become an integral part of the future healthcare landscape, writes Shveta Garg while taking us through the current status of the market and future perspectives...............

Nascent, but Indian genome sequencing market will take off soon

Experts suggest that it is a matter of time when products in genome sequencing will become affordable and the Indian genome sequencing market will progress towards maturity.................

Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI

Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................